JATHEME Trademark

Trademark Overview

On Tuesday, April 5, 2011, a trademark application was filed for JATHEME with the United States Patent and Trademark Office. The USPTO has given the JATHEME trademark a serial number of 85287246. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 8, 2013. This trademark is owned by Affymax Pharma Limited. The JATHEME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, renal failure, anoxia-induced cellular degeneration, and hypoxia-induced cellular degeneration
jatheme

General Information

Serial Number85287246
Word MarkJATHEME
Filing DateTuesday, April 5, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 8, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2012

Trademark Statements

Goods and ServicesPharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, renal failure, anoxia-induced cellular degeneration, and hypoxia-induced cellular degeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 8, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAffymax Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB
Party NameAffymax Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC2A 2RS
GB

Trademark Events

Event DateEvent Description
Friday, October 11, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 8, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 8, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 4, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 23, 2012TTAB RELEASE CASE TO TRADEMARKS
Tuesday, October 23, 2012OPPOSITION TERMINATED NO. 999999
Tuesday, October 23, 2012OPPOSITION DISMISSED NO. 999999
Friday, October 12, 2012PAPER RECEIVED
Monday, August 20, 2012OPPOSITION INSTITUTED NO. 999999
Wednesday, March 14, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 14, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2012PUBLISHED FOR OPPOSITION
Wednesday, January 25, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 11, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 6, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 6, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 6, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 19, 2011ASSIGNED TO LIE
Thursday, December 15, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 23, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 23, 2011NON-FINAL ACTION E-MAILED
Thursday, June 23, 2011NON-FINAL ACTION WRITTEN
Tuesday, June 21, 2011ASSIGNED TO EXAMINER
Friday, April 8, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 8, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

jatheme pharmaceuticals induced cellular degeneration hypoxia failure anoxia renal cancer human